Protocol N. 2014 - Observational Study on the Quality of Life of Outpatients
Launched by IRCCS SAN RAFFAELE · Jan 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Protocol N. 2014," is looking at the quality of life for men with various urologic conditions, including issues related to male infertility and sexual health. The study involves collecting information from patients who visit specific urology clinics, including general urology, sexual medicine, and uro-oncology. The goal is to understand how these conditions affect patients' everyday lives, both physically and psychologically, by gathering their responses through questionnaires.
To participate in this study, men aged 18 and older who are being treated for urologic diseases can join if they give their consent. However, those who are under 18 or have certain mental or physical disabilities that prevent them from responding to the questionnaires will not be eligible. Participants can expect to share their experiences and feelings about their health, which will help researchers learn more about how to improve care for men facing these challenges. The study is currently recruiting participants, so it’s a great opportunity to contribute to research that could benefit many others in the future.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • subjects belonging to general urology, sexual medicine, reproductive medicine, functional urology, neuro-urology and uro-oncology clinics.
- • subjects \>= 18 years old
- • signature of informed consent
- Exclusion Criteria:
- • - subjects \< 18 years
- • presence of mental or physical disability that may prevent the patient from answering the questionnaires.
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, Lombardy, Italy
Patients applied
Trial Officials
Andrea Salonia, MD
Principal Investigator
IRCCS Ospedale San Raffaele
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported